Dartmouth-Hitchcock Medical Center
580
61
80
377
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 75/100
15.2%
88 terminated/withdrawn out of 580 trials
81.1%
-5.4% vs industry average
8%
44 trials in Phase 3/4
42%
160 of 377 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (580)
iPath for CP Pilot
Role: lead
Improving Care, Accelerating Recovery and Education
Role: lead
Implementation of the ACP Guideline for Low Back Pain (IMPACt-LBP)
Role: collaborator
Testing a Mammography Decision Intervention in a Rural Setting
Role: lead
aPBI Re-irradiation
Role: lead
Psychosocial Skills Group for Pelvic Floor Symptoms
Role: lead
Phase II Study of Neoadjuvant ArOMatase Inhibitor Therapy for ER+ Breast Cancer (NAOMI)
Role: lead
Feasibility of Modulating Cognitive Control in OCD
Role: lead
RISE: A Remote Study of Insomnia Treatment in Crohn's Disease
Role: lead
Self-administered ONe-of-a Kind Approach to Epilepsy Therapy Through a Web-based Music Application
Role: lead
Once Daily Intrapleural Enzyme Therapy in Complicated Parapneumonic Effusion or Empyema
Role: collaborator
Comparing Healthcare Visit Recording and Open Notes to Improve Chronic iLlness Care Experience in Older Adults
Role: lead
Flush, Lyse, Operate
Role: lead
Video Inspired Discussions About Ethical Outcomes in Pediatrics
Role: collaborator
TF-CBT for Autistic Youth Pilot Implementation - Open Pilot
Role: lead
Computer Guided Microwave Liver Ablation
Role: collaborator
A Randomized Two-Arm Proof of Concept Study Testing A Novel Approach to Exercise Promotion Based on Affect-regulation
Role: lead
Descemet Endothelial Thickness Comparison Trial I
Role: collaborator
Descemet Endothelial Thickness Comparison Trial II
Role: collaborator
Colonoscopy vs Stool Testing for Older Adults With Colon Polyps
Role: lead